ask="4.11"
ask_size="100"
average_daily_volume="25912"
bid="3.23"
bid_size="500"
book_value="0.89"
change="+0.08"
change_from_200_day_moving_average="-1.63"
change_from_50_day_moving_average="-0.71"
change_from_52_week_high="-5.96"
change_From_52_week_low="0.56"
change_in_percent="+2.11%"
close="3.88"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.88"
ebitda="0.00"
eps_estimate_current_year="-2.21"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.70"
ex_dividend_date="N/A"
float_shares="8264000"
high="4.00"
high_52_weeks="9.84"
last_trade_date="12/30/2016"
last_trade_price="3.88"
last_trade_size="2300"
last_trade_time="4:00pm"
low="3.32"
low_52_weeks="3.32"
market_capitalization="32.51M"
moving_average_200_day="5.51"
moving_average_50_day="4.59"
name="TapImmune Inc."
notes="N/A"
one_year_target_price="83.64"
open="3.79"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-29.62%"
percent_change_from_50_day_moving_average="-15.49%"
percent_change_from_52_week_high="-60.57%"
percent_change_from_52_week_low="+16.87%"
previous_close="3.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.26"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="0.19"
stock_exchange="NCM"
symbol="TPIV"
volume="72834"
weeks_range_52="3.32 - 9.84"
